/ /

  • linkedin
  • Increase Font
  • Sharebar

    A cutting-edge focus


    A cutting-edge focus

    Introducing a sharpened vision for innovation, insights, discoveries

    “The only thing that is constant is change.”

    —Heraclitus, Greek philosopher in 500 BC


    Heraclitus was known for his doctrine of change being central to the cosmos. Like Heraclitus’ universe, ophthalmology is constantly in a state of change. Always has been, always will. We’re seeing more and more shifts in how ophthalmologists practice medicine—and that transformation will undoubtedly continue as we advance through the 21st century.

    Ophthalmology is already facing many transitions in social, patient, and professional demographics—how we treat patients, even how we perform surgery. This is becoming more evident as new technology emerges.

    All this change makes it difficult for ophthalmologists to stay on top of cutting-edge advancements. Aside from the clinic, readers also are challenged by the multitude of peer-reviewed content and other publications to find the latest advancements in the field.

    Understanding these challenges, Ophthalmology Times is retooling its editorial direction, transitioning from a clinical newsmagazine to a resource that will explore the innovative concepts, insights, and discoveries in ophthalmology.

    Beginning with this issue, Ophthalmology Times will present cutting-edge advancements from around the world in four distinct categories:

    > Surgery will highlight the latest surgical techniques and technology across all subspecialties of ophthalmology, especially cataract, refractive, glaucoma, and retina.

    > Drug therapy will keep readers connected to the latest pharmaceutical advancements, with updates to existing drugs and those pharmaceuticals making their way through the clinical pipeline.

    > Clinical diagnosis will update readers on the latest treatments and therapies in clinical care.

    > Technology will spotlight the new products and scientific ingenuity that surface from labs of industry and exhibit halls of major ophthalmic meetings.

    The driving force behind this new direction is the Ophthalmology Times Editorial Advisory Board (EAB). The board consists of more than 50 of the most innovative and influential ophthalmologists.

    Their expertise, knowledge, and leadership will identify the innovations that continually permeate ophthalmology. The EAB will engage more with readers by providing articles about clinical advances and technologies, as well as opinion articles and clinical perspective and analysis within the various subspecialties.

    Readers can expect to see more articles from physicians and other key opinion leaders. Ophthalmology Times also has developed new columns and added new editors to its existing columns. Physician-to-physician articles will also drive additional content through Ophthalmology Times’ digital channels with videos, podcasts, and online article exclusives.

    Finally, with new direction comes a new mission for Ophthalmology Times. The publication’s new mission statement reflects these changes as we move into the digital age—today and in the future:

    > Ophthalmology Times is a physician-driven media brand that presents cutting-edge advancements and analysis from around the world in surgery, drug therapy, technology, and clinical diagnosis to elevate the delivery of progressive eye health from physician to patient.

    > Ophthalmology Times’ vision is to be the leading content resource for ophthalmologists.

    > Through its multifaceted content channels, Ophthalmology Times will assist physicians with the tools and knowledge necessary to provide advanced quality patient care in the global world of medicine.

    Ophthalmology Times has been a physician-driven media brand. This new direction will only solidify the editorial forum and build on the editorial success that Ophthalmology Times has established for almost 40 years. 

    Peter J. McDonnell, MD
    He is director of The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, and chief medical editor of ...

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results